Filing Details

Accession Number:
0001209191-19-031370
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-20 16:20:19
Reporting Period:
2019-05-17
Accepted Time:
2019-05-20 16:20:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108109 Community Health Systems Inc CYH Services-General Medical & Surgical Hospitals, Nec (8062) 133893191
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463791 Iii S. James Ely 4000 Meridian Blvd
Franklin TN 37067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-17 50,000 $3.25 136,320 No 4 P Direct
Common Stock Acquisiton 2019-05-20 50,000 $3.15 186,320 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,990 Indirect By E5 Investors LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Restricted Stock Units $0.00 2018-03-01 2027-02-28 6,166 6,166 Direct
Common Stock Restricted Stock Units $0.00 2019-03-01 2028-02-28 24,745 24,745 Direct
Common Stock Restricted Stock Units $0.00 2020-03-01 2029-02-28 34,068 34,068 Direct
Common Stock Stock Units (SU) $0.00 15,968 15,968 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-02-28 6,166 6,166 Direct
2028-02-28 24,745 24,745 Direct
2029-02-28 34,068 34,068 Direct
15,968 15,968 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/20/2019 at prices ranging from $3.145 to $3.150, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and will be settled 100% in the Company's common stock upon cessation as a director or upon a date specified by the director.